EUVIMEDEUVIMED entdecken
Crossref

Gene Replacement in Tanycytes Ameliorates Neurological Consequences of Mct8 Deficiency in Mice

Adriana Arrulo Pereira, Helge Müller-Fielitz, Julica Inderhees, Eva Novoa, Akila Chandrasekar, Ümit Özorhan, Sreekala Nampoothiri, Yvon Mbouamboua iD, Riccardo Dore iD, Heike Heuer iD, Urte Matschl, Sonja Binder und 5 weitere

Thyroid® · 17.11.2026

DOI: 10.1177/10507256261506754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, online erschienen am 17.11.2026. Verfasst von Adriana Arrulo Pereira und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Experimental and Clinical Pharmacology and Toxicology, Center of Brain, Behavior and Metabolism (CBBM), University of Luebeck, Luebeck,…. Die Arbeit nennt 44 Literaturangaben. Gefördert von: H2020 European Research Council, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

MCT8 transports thyroid hormones into the central nervous system. A genetic deficiency of MCT8 leads to hypothyroidism in the brain and severe neurological symptoms, a condition known as Allan–Herndon–Dudley syndrome (AHDS). Replacing MCT8 with gene therapy could effectively treat AHDS, but the most suitable target cell is yet to be identified. Since endogenous Mct8 is expressed by the glial tanycytes that form the blood–cerebrospinal fluid barrier in the hypothalamus, we tested the efficacy of tanycyte-directed gene therapy.

Methods

We used Mct8 −/− mice on an Oatp1c1 −/− background (double knockout, DKO) as a model of AHDS to avoid compensation of OATP1C1 for MCT8 deficiency. After DKO mice received an intracerebroventricular injection of an adeno-associated virus encoding Mct8 at postnatal day 40, we investigated endocrine and neurological parameters of the disease.

Results

The gene therapy approach restored Mct8 expression and normalized thyrotropin releasing hormone-induced signaling in DKO tanycytes, suggesting intact MCT8 function in these cells. Although MCT8 rescue in tanycytes did not correct the overactive hypothalamus–pituitary–thyroid axis in DKO mice, it improved triiodothyronine concentrations and gene expression in the cortex. Furthermore, it counteracted the reduction in brain weight in DKO mice.

Conclusions

Gene therapy targeting tanycytes improves neurological parameters in mice with Mct8 deficiency. Further research is needed to determine whether this approach could be used to treat AHDS.

Schlagwörter

Stichwörter der Autor:innen

gene therapyhyperthyroidismintellectual disabilitythyroid hormone transporter

Autor:innen und Institutionen

  • Institute for Experimental and Clinical Pharmacology and Toxicology, Center of Brain, Behavior and Metabolism (CBBM), University of Luebeck, Luebeck, Germany.
  • Bioanalytic Core Facility, Center of Brain, Behavior and Metabolism, University of Luebeck, Luebeck, Germany.
  • Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S 1172, European Genomic Institute for Diabetes (EGID), University of Lille, Lille, France.
  • Institute for Experimental Endocrinology, Center of Brain, Behavior and Metabolism (CBBM), University of Luebeck, Luebeck, Germany.
  • Department of Endocrinology, Diabetes and Metabolism and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University Duisburg-Essen, Essen, Germany.

ORCID-Profile: Yvon Mbouamboua, Riccardo Dore, Heike Heuer, Surya Rai, Markus Schwaninger

Förderung

  • H2020 European Research Council
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Arrulo Pereira, A., Müller-Fielitz, H., Inderhees, J., Novoa, E., Chandrasekar, A., Özorhan, Ü., Nampoothiri, S., Mbouamboua, Y., Dore, R., Heuer, H., Matschl, U., Binder, S., Rai, S., Mittag, J., Prevot, V., Nogueiras, R., & Schwaninger, M. (2026). Gene Replacement in Tanycytes Ameliorates Neurological Consequences of Mct8 Deficiency in Mice. Thyroid®. https://doi.org/10.1177/10507256261506754

Vancouver

Arrulo Pereira A, Müller-Fielitz H, Inderhees J, Novoa E, Chandrasekar A, Özorhan Ü, et al. Gene Replacement in Tanycytes Ameliorates Neurological Consequences of Mct8 Deficiency in Mice. Thyroid®. 2026. doi:10.1177/10507256261506754

BibTeX
@article{ArruloPereira2026,
  author = {Arrulo Pereira, Adriana and Müller-Fielitz, Helge and Inderhees, Julica and Novoa, Eva and Chandrasekar, Akila and Özorhan, Ümit and Nampoothiri, Sreekala and Mbouamboua, Yvon and Dore, Riccardo and Heuer, Heike and Matschl, Urte and Binder, Sonja and Rai, Surya and Mittag, Jens and Prevot, Vincent and Nogueiras, Ruben and Schwaninger, Markus},
  title = {Gene Replacement in Tanycytes Ameliorates Neurological Consequences of Mct8 Deficiency in Mice},
  journal = {Thyroid®},
  year = {2026},
  doi = {10.1177/10507256261506754}
}
Kostenlos starten →